Leitlinienprogramm OnkologiePancreatic Cancer

13. Tabellenverzeichnis – Pancreatic Cancer

Version 3.0 · March 2024 · AWMF 032/010OL
Leitlinienprogramm Onkologie · Deutsche Krebsgesellschaft · Deutsche Krebshilfe · AWMF

Beteiligte Fachgesellschaften und Organisationen

Arbeitsgruppen

Abkürzungen

Risk of Developing Pancreatic Carcinoma Depending on Individual Types of Food

Risk of Developing Pancreatic Carcinoma Depending on the Consumption of Stimulants

Risk of Developing Pancreatic Carcinoma Depending on Lifestyle Habits

Risk of Developing Pancreatic Carcinoma Depending on Pre-existing Conditions

Genes and Syndromes Associated with an Increased Risk of Pancreatic Cancer [based on Table 1 from Stoffel et al. 2018 [122]]

Age- and Suspicion Level-adapted Diagnostic Approach to Newly-onset Upper Abdominal and Back Pain

Diagnostic value of magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography combined with CT (PET/CT), endosonography (EUS), and transabdominal ultrasound (US) for the diagnosis of pancreatic cancer

Recommended Procedure in the Presence of a Side-branch IPMN

ABC criteria of resectability according to the International Association of Pancreatology (IAP) consensus (Isaji et al.)

Classification of CT/MRI-based anatomical resectability in pancreatic cancer according to National Comprehensive Cancer Network (NCCN) criteria

Structured report template for CT/MRI reporting of solid and cystic pancreatic lesions, based on the consensus-based report templates of the German Radiological Society (DRG)

Changes in Version 3